Pain
Conditions
Interventions
This is a randomized, placebo-controlled, double-blind clinical trial to be conducted with 45 young, healthy men with no recent experience in upper limb strength training, aged between 18 and 35 years
Sponsors
Universidade Estadual do Sudoeste da Bahia
Universidade Estadual do Sudoeste da Bahia
Eligibility
Sex/Gender
Male
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Be a healthy male, aged 18-35 years and classified as irregularly active or active in the International Physical Activity Questionaire (IPAQ); Not being involved in strength training programs for upper limbs; not with a body mass index (BMI) of less than 18.5 kg / m-2 and greater than 30 kg / m-2; not be smokers or who use vasoactive medications and nutritional supplements regularly. Do not report musculoskeletal injury to lower limbs within 3 months prior to testing; not having uncontrolled diabetes mellitus or blood pressure; have no inflammatory rheumatologic condition or severe cardiovascular and / or pulmonary disease that prevents them from performing the evaluation and the proposed exercise; not having psychiatric disease and malignant tumors; not have presented Zika or Chikungunya in the last year
Exclusion criteria
Exclusion criteria: Missing some day of collection; at any time and for any reason expressing an intention to leave the study; present a health problem that prevents them from continuing to participate in the research; use of medications, electrotherapeutic equipment or other therapeutic resources to improve pain and performance during the collection period; practicing unusual or strenuous physical activities during the days of collection; Volunteers who smoke; history of alcohol or drug abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Delayed-onset muscle soreness measured by the visual analogue pain scale (VAS) of 100 millimeters, where 0 is understood as no pain and 100 as the largest pain ever experienced by the volunteer. An average difference of at least 20 points in the EVA is expected | — |
Secondary
| Measure | Time frame |
|---|---|
| Isometric torque measured by isokinetic dynamometer;Knee range of motion measured by goniometry. A 5 to 50% change in range of motion is expected;Thigh circumference measured by perimetry. A change of 5 to 50% in circumference is expected;Serum creatine kinase levels measured from blood sample collection. A 5 to 50% change in serum creatine levels is expected;Perception of discomfort during preconditioning ischemia and perception of effort during eccentric exercise measured using the visual analogue scale (VAS) from 0 to 100 millimeters and the Borg scale, respectively. A change of 5 to 50% is expected in these outcomes | — |
Countries
Brazil
Contacts
Public ContactMikhail Santos Cerqueira
Universidade Estadual do Sudoeste da Bahia
Outcome results
None listed